Danilo Galizia - Publications

Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trial.

Journal: ESMO open

Published: December 06, 2024

Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 06, 2023

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment.

Journal: Cancers

Published: October 04, 2023

Current evidence on diagnosis and treatment of parotid gland lymphomas: a systematic review.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: August 09, 2023

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib.

Journal: Vaccines

Published: December 22, 2022

How Risk Factors Affect Head and Neck Squamous Cell Carcinoma (HNSCC) Tumor Immune Microenvironment (TIME): Their Influence on Immune Escape Mechanisms and Immunotherapy Strategy.

Journal: Biomedicines

Published: September 08, 2022

Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking.

Journal: Oncology

Published: August 12, 2022

The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.

Journal: PloS one

Published: August 11, 2022

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review.

Journal: Biomedicines

Published: June 08, 2022

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression.

Journal: Vaccines

Published: November 06, 2021

A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study.

Journal: Diagnostics (Basel, Switzerland)

Published: May 10, 2021

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer.

Journal: Drug design, development and therapy

Published: April 12, 2021